GLP-1 Weight Loss for Men: Is It Right for You?

Disclosure: This post contains affiliate links. If you purchase through them, we may earn a commission at no extra cost to you. We only recommend products that meet our evidence standard.

GLP-1 weight loss for men is worth a conversation with a prescriber if the FDA labels fit you: for weight reduction, adults with obesity, or overweight with at least one weight-related condition. In one pooled analysis that did not name tirzepatide, men lost less weight on average than women, and in the withdrawal trials substantial weight came back after treatment stopped. This page is a decision guide. It’s part of our weight loss for men over 50 guide, and the drug basics are in GLP-1 for men over 50.

Table of Contents

Do Men Lose Less Weight Than Women on GLP-1 Medications?

On average, yes, in that pooled analysis. A 2026 meta-analysis in JAMA Internal Medicine from Johns Hopkins pooled six trials analyzed by sex, covering 19,906 patients. Weight loss was 10.9% in women (95% CI 7.0% to 14.8%) and 6.8% in men (95% CI 4.6% to 9.0%).

Two limits matter. The abstract names semaglutide, liraglutide, exenatide, lixisenatide and dulaglutide as the GLP-1 receptor agonists it covered, and it does not name tirzepatide. And those are averages across trials, so they can’t tell you what one man will lose.

Does Age Change the Result for Men Over 50?

Not in that analysis, which covered adults generally rather than men over 50 specifically. The authors found no significant difference in weight change by age (7 trials, 4,314 patients), baseline BMI or baseline HbA1c. They concluded efficacy was consistent across the other subgroups, with sex the exception.

Do GLP-1 Medications Raise Testosterone in Men?

The evidence is limited. A 2025 meta-analysis in Andrology pooled seven studies of 680 men with overweight or obesity and found total testosterone rose after GLP-1 treatment. The authors suggest a possible role in functional hypogonadism linked to overweight and obesity.

They also say the current literature does not allow them to demonstrate a direct action on testicular function. Neither the Wegovy label nor the Zepbound label mentions testosterone, so these medications aren’t labeled for low testosterone. If you suspect low testosterone, that’s a separate conversation with your doctor.

What Does GLP-1 Treatment Look Like Week by Week?

You don’t start at the full dose. The labels build in a gradual step-up, and the Wegovy and Zepbound labels say the step-up is meant to reduce the risk of gastrointestinal side effects.

Wegovy Injection and Tablets

Injection: 0.25 mg once weekly for weeks 1 to 4, 0.5 mg for weeks 5 to 8, 1 mg for weeks 9 to 12, then 1.7 mg for weeks 13 to 16. The label’s recommended maintenance dose is 2.4 mg once weekly.
Tablets: once daily at 1.5 mg for the first 30 days, 4 mg for days 31 to 60, 9 mg for days 61 to 90, then 25 mg from day 91.
If two or more consecutive injection doses are missed, the label says to restart the step-up at a lower dose.

Zepbound Injection

Zepbound starts at 2.5 mg once weekly for 4 weeks, then goes to 5 mg. After that, the dose can rise in 2.5 mg steps, after at least 4 weeks on each dose. The labeled maintenance doses for weight reduction are 5, 10 or 15 mg, and 15 mg is the maximum.

What Happens If a Man Stops Taking a GLP-1 Medication?

Substantial weight came back in both trials that tested this directly. Both were mostly women, so they don’t describe men specifically.

Semaglutide Withdrawal in the STEP 1 Extension

In an off-treatment follow-up of 327 STEP 1 participants, mean weight loss at week 68 was 17.3% on semaglutide 2.4 mg. A year after treatment and the lifestyle program stopped, they had regained 11.6 percentage points, leaving a net loss of 5.6% from the start. The authors said participants regained two-thirds of their prior loss. The analyses were exploratory, and Novo Nordisk employees are among the authors.

Tirzepatide Withdrawal in SURMOUNT-4

SURMOUNT-4 gave 783 adults tirzepatide for 36 weeks, with a mean weight reduction of 20.9% among the 670 who were then randomized (mean age 48, 71% women). From week 36 to week 88, weight changed by -5.5% in those who kept taking it and rose 14.0% in those switched to placebo. At 88 weeks, 89.5% of the continuing group had kept at least 80% of their lead-in loss, against 16.6% of the placebo group.

How Do I Know If GLP-1 Weight Loss Is Right for Me?

It comes down to five questions to settle with a prescriber.

Do you fit the label? For weight reduction, it covers adults with obesity, or overweight with at least one weight-related condition, used alongside a reduced-calorie diet and more physical activity.
Are you ready to stay on it? The STEP 1 extension authors say their findings suggest ongoing treatment is required.
Will you change how you eat and train? Both labels pair the drug with diet and activity.
Does your history rule it out? Both labels list a personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2, as a contraindication.
Do you have a muscle plan? Our guide to keeping muscle on GLP-1 is worth reading first.

My read: if you’re on the fence, treat this as a long-term health decision made with a doctor, not a 12-week fix. A man who’s ready to commit for years and to change how he eats and trains is in a different spot than one hoping for a quick drop.

What Should I Tell the Prescriber Before Starting?

Bring a full medication list. The Wegovy label says using it with insulin or an insulin secretagogue may raise the risk of low blood sugar, and the Zepbound label says combining it with other tirzepatide products or any GLP-1 receptor agonist is not recommended. Both labels also ask you to report any planned surgery or procedure, because rare postmarketing reports describe pulmonary aspiration during general anesthesia or deep sedation in patients receiving GLP-1 receptor agonists. Our GLP-1 side effects guide covers which side effects to watch for after you start.

How Can Men Get a GLP-1 Prescription Online?

A licensed clinician has to prescribe it, and telehealth only changes how you reach one. ShedRX, which its page brands as Shed, is one telehealth option. Its page describes a 100% online visit and checkout, and its list includes Wegovy and Zepbound plus compounded semaglutide and tirzepatide injections. It also says compounded medications are not FDA-approved, and that a prescription is issued only after a consultation with a licensed provider who determines whether treatment is appropriate.

If you decide to try it, start with ShedRX’s online consultation and tell your own doctor too. A prescriber decides whether treatment fits you and which medication. Prices change, so check the current price on the provider’s page.

Medical disclaimer: This page is for general information and is not medical advice. GLP-1 medications are prescription drugs. Talk to a licensed clinician about whether one is appropriate for you, and do not start, stop or change a medication without that conversation.

Frequently Asked Questions

Do men lose as much weight on GLP-1 medications as women?

Not on average in the pooled trial data. In six trials covering 19,906 patients, average weight loss was 6.8% in men and 10.9% in women. Individual results vary a lot.

Will I regain the weight if I stop a GLP-1 medication?

A substantial share, in the two withdrawal trials. After semaglutide stopped, participants regained about two-thirds of their loss within a year. In SURMOUNT-4, weight rose 14.0% after switching tirzepatide to placebo.

Can GLP-1 medications raise testosterone?

A meta-analysis of seven studies in men with overweight or obesity found total testosterone rose after treatment. The authors say the literature doesn’t allow them to demonstrate a direct action on testicular function, and the medications aren’t labeled for low testosterone.

How long does it take to reach the full dose?

About four months for Wegovy injection: the label’s step-up runs through week 16 and maintenance starts at week 17. Zepbound starts at 2.5 mg for four weeks, then rises in 2.5 mg steps after at least four weeks on each dose until the prescriber reaches a maintenance dose.

Can I take a GLP-1 medication if I only want to lose 20 pounds?

The labels are written around obesity, or overweight with a weight-related condition, not a number of pounds. A clinician looks at your health history and decides whether you qualify.

Do I need a prescription for GLP-1 weight loss medications?

Yes. Wegovy and Zepbound are prescription weight loss medications, and the ShedRX page says a prescription is issued only after a consultation with a licensed provider.

Sources